• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Acquired erythropoietic protoporphyria secondary to myelodysplastic syndrome: from mythology to oncologyAcquired Erythropoietic Protoporphyria Secondary to Myelodysplastic Syndrome: From Mythology to Oncology.

作者信息

Urosevic-Maiwald Mirjana, Kamarachev Jivko, Renner Christoph, Minder Anna-Elisabeth

机构信息

Hautärzte-Zentrum am Zürisee, Zurich, Switzerland.

Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.

出版信息

Acta Derm Venereol. 2024 Aug 28;104:adv41146. doi: 10.2340/actadv.v104.41146.

DOI:10.2340/actadv.v104.41146
PMID:39193932
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11370046/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7643/11370046/b947a1fe57e9/ActaDV-104-41146-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7643/11370046/b947a1fe57e9/ActaDV-104-41146-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7643/11370046/b947a1fe57e9/ActaDV-104-41146-g001.jpg

相似文献

1
Acquired erythropoietic protoporphyria secondary to myelodysplastic syndrome: from mythology to oncologyAcquired Erythropoietic Protoporphyria Secondary to Myelodysplastic Syndrome: From Mythology to Oncology.骨髓增生异常综合征继发获得性红细胞生成性原卟啉症：从神话到肿瘤学 骨髓增生异常综合征继发获得性红细胞生成性原卟啉症：从神话到肿瘤学
Acta Derm Venereol. 2024 Aug 28;104:adv41146. doi: 10.2340/actadv.v104.41146.
2
Case of late-onset erythropoietic protoporphyria with myelodysplastic syndrome who has homozygous IVS3-48C polymorphism in the ferrochelatase gene.伴有骨髓增生异常综合征的迟发性红细胞生成性原卟啉症病例，其 ferrochelatase 基因存在纯合子 IVS3-48C 多态性。
J Dermatol. 2017 Jun;44(6):651-655. doi: 10.1111/1346-8138.13709. Epub 2016 Dec 27.
3
A case of late onset erythropoietic protoporphyria associated with myelodysplastic syndrome treated by the combination of beta carotene and azacitidine.一例迟发性红细胞生成性原卟啉症合并骨髓增生异常综合征经β-胡萝卜素和阿扎胞苷联合治疗的病例
Ann Hematol. 2013 Oct;92(10):1415-6. doi: 10.1007/s00277-013-1720-6. Epub 2013 Mar 9.
4
Late-onset Erythropoietic Protoporphyria Associated with Myelodysplastic Syndrome Treated with Azacitidine.与采用阿扎胞苷治疗的骨髓增生异常综合征相关的迟发性红细胞生成性原卟啉症
Acta Derm Venereol. 2018 Feb 7;98(2):275-277. doi: 10.2340/00015555-2829.
5
Acquired erythropoietic protoporphyria.获得性红细胞生成性原卟啉症
Ann Hematol. 2010 Jul;89(7):743-4. doi: 10.1007/s00277-009-0859-7. Epub 2009 Nov 10.
6
Extreme photosensitivity in a patient with erythropoietic protoporphyria.一名红细胞生成性原卟啉病患者的极度光敏性。
Br J Hosp Med (Lond). 2015 Jan;76(1):52-3. doi: 10.12968/hmed.2015.76.1.52.
7
[Anaemia and photosensitization might point to erythropoietic protoporphyria].贫血和光敏反应可能提示红细胞生成性原卟啉病。
Ann Dermatol Venereol. 2011 Jan;138(1):54-5. doi: 10.1016/j.annder.2010.08.004.
8
Recovery From Severe Systemic Peripheral Neuropathy Secondary to Erythropoietic Protoporphyria by Liver Transplant: A Case Report.红细胞生成性原卟啉症继发严重系统性周围神经病的肝移植治疗：病例报告。
Exp Clin Transplant. 2022 Oct;20(10):954-958. doi: 10.6002/ect.2022.0157.
9
Acquired erythropoietic protoporphyria as a result of myelodysplasia causing loss of chromosome 18.因骨髓发育异常导致18号染色体缺失而引发的获得性红细胞生成性原卟啉症。
Br J Dermatol. 2006 Aug;155(2):464-6. doi: 10.1111/j.1365-2133.2006.07318.x.
10
Erythropoietic protoporphyria presenting with liver failure in adulthood.成年期出现肝功能衰竭的红细胞生成性原卟啉病。
Dermatology. 2005;210(1):72-3. doi: 10.1159/000081490.

本文引用的文献

1
Multiple milia formation in blistering diseases.水疱性疾病中的多发性粟丘疹形成。
Int J Womens Dermatol. 2020 Apr 1;6(3):199-202. doi: 10.1016/j.ijwd.2020.03.045. eCollection 2020 Jun.
2
Acquired erythropoietic protoporphyria: A systematic review of the literature.获得性红细胞生成性原卟啉症：文献系统综述。
Photodermatol Photoimmunol Photomed. 2020 Jan;36(1):29-33. doi: 10.1111/phpp.12501. Epub 2019 Aug 21.
3
Porphyrin-Induced Protein Oxidation and Aggregation as a Mechanism of Porphyria-Associated Cell Injury.卟啉诱导的蛋白氧化和聚集作为卟啉病相关细胞损伤的机制。
Cell Mol Gastroenterol Hepatol. 2019;8(4):535-548. doi: 10.1016/j.jcmgh.2019.06.006. Epub 2019 Jun 21.
4
Late-onset Erythropoietic Protoporphyria Associated with Myelodysplastic Syndrome Treated with Azacitidine.与采用阿扎胞苷治疗的骨髓增生异常综合征相关的迟发性红细胞生成性原卟啉症
Acta Derm Venereol. 2018 Feb 7;98(2):275-277. doi: 10.2340/00015555-2829.
5
Case of late-onset erythropoietic protoporphyria with myelodysplastic syndrome who has homozygous IVS3-48C polymorphism in the ferrochelatase gene.伴有骨髓增生异常综合征的迟发性红细胞生成性原卟啉症病例，其 ferrochelatase 基因存在纯合子 IVS3-48C 多态性。
J Dermatol. 2017 Jun;44(6):651-655. doi: 10.1111/1346-8138.13709. Epub 2016 Dec 27.
6
Afamelanotide for Erythropoietic Protoporphyria.阿法美拉肽用于治疗红细胞生成性原卟啉症。
N Engl J Med. 2015 Jul 2;373(1):48-59. doi: 10.1056/NEJMoa1411481.
7
Long-term observational study of afamelanotide in 115 patients with erythropoietic protoporphyria.长程观察研究阿法美拉诺肽治疗 115 例红细胞生成性原卟啉症患者。
Br J Dermatol. 2015 Jun;172(6):1601-1612. doi: 10.1111/bjd.13598. Epub 2015 Apr 30.
8
Acquired erythropoietic protoporphyria.获得性红细胞生成性原卟啉症
Ann Hematol. 2010 Jul;89(7):743-4. doi: 10.1007/s00277-009-0859-7. Epub 2009 Nov 10.